>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Acadia Realty Trust (AKR) upgraded to Overweight from Sector Weight at KeyBanc, tgt $25
    • America Movil (AMX) upgraded to Overweight from Neutral at JPMorgan, tgt $32
    • Americold Realty Trust (COLD) upgraded to Neutral from Underperform at BofA Securities, tgt $16
    • Bath & Body Works (BBWI) upgraded to Buy from Neutral at Citi, tgt $25
    • Duolingo (DUOL) upgraded to Buy from Neutral at DA Davidson, tgt $160
  • Downgrades:
    • Abercrombie & Fitch (ANF) downgraded to Market Perform from Outperform at Raymond James
    • Ameresco (AMRC) downgraded to Neutral from Outperform at Baird, tgt $32
    • Autohome (ATHM) downgraded to Underperform from Neutral at BofA Securities, tgt $19
    • EyePoint (EYPT) downgraded to Neutral from Buy at H.C. Wainwright
    • EyePoint (EYPT) downgraded to Sector Perform from Outperform at RBC Capital, tgt $5
    • Globalstar (GSAT) downgraded to Hold from Buy at Craig-Hallum, tgt $90
    • Hermes (HESAY) downgraded to Sector Perform from Outperform at RBC Capital
    • Kite Realty Group (KRG) downgraded to Sector Weight from Overweight at KeyBanc
    • Millicom (TIGO) downgraded to Neutral from Overweight at JPMorgan, tgt $105
    • Norwegian Cruise Line (NCLH) downgraded to Neutral from Outperform at Mizuho, tgt $17
    • Ramaco Resources (METC) downgraded to Neutral from Outperform at Baird, tgt $13
  • Others:
    • Centrus Energy (LEU) initiated with an Equal Weight at Barclays, tgt $207
    • Corcept Therapeutics (CORT) assumed with a Buy at Truist, tgt $164
    • Definium Therapeutics (DFTX) initiated with a Buy at BofA Securities, tgt $75
    • Editas Medicine (EDIT) initiated with a Buy at Ladenburg Thalmann, tgt $6
    • Enliven Therapeutics (ELVN) initiated with an Overweight at Barclays, tgt $78
    • Enliven Therapeutics (ELVN) initiated with an Outperform at William Blair
    • Freenome (FRNM) initiated with a Buy at TD Cowen, tgt $17
    • Gorilla Technology (GRRR) initiated with a Buy at Compass Point, tgt $44
    • Hilton Grand Vacations (HGV) initiated with a Neutral at Susquehanna, tgt $50
    • Kanzhun (BZ) initiated with a Neutral at BofA Securities, tgt $19
    • Marriott Vacations Worldwide (VAC) initiated with a Neutral at Susquehanna, tgt $110
    • Nuvation Bio (NUVB) initiated with an Overweight at JPMorgan, tgt $13
    • Obsidian Therapeutics (OBX) initiated with an Outperform at LifeSci Capital, tgt $43
    • Rani Therapeutics (RANI) initiated with a Buy at Chardan, tgt $6
    • Scribe Therapeutics (SCTX) initiated with an Early-Stage Biotech rating at Goldman Sachs
    • Scribe Therapeutics (SCTX) initiated with a Buy at Guggenheim, tgt $50
    • Scribe Therapeutics (SCTX) initiated with an Outperform at Leerink, tgt $37
    • Scribe Therapeutics (SCTX) initiated with an Overweight at Wells Fargo, tgt $60
    • Sinda (SIND) initiated with a Speculative Buy at Canaccord, tgt $19
    • Sunshine Silver Mining (SSMR) initiated with a Speculative Buy at Canaccord, tgt $20
    • Travel + Leisure (TNL) initiated with a Positive at Susquehanna, tgt $95
    • WaterBridge Infrastructure (WBI) resumed with an Overweight at JPMorgan, tgt $38